does semaglutide stop working over time While nearly 18% of U.S. adults have taken a GLP-1 drug for weight loss or to treat a chronic condition, about half of people will taking it within a year. Often Half of people stop taking

Government platforms : Medicare's GLP-1 Bridge program will offer $50/month access for eligible beneficiaries starting July 2026

Reduces oxidative stress that accelerates follicle aging

Regulatory Timeline and Expectations CagriSema (Cagrilintide + Semaglutide): FDA review ongoing for obesity indication European Medicines Agency (EMA) submission completed Potential approval expected in late 2026 or early 2027 Would represent first approved amylin analogue combination therapy Cagrilintide Monotherapy: Less likely to be pursued as standalone therapy Combination approaches show superior efficacy May remain primarily a research tool Emerging Research Questions Key questions driving current research include: Optimal combination partners Beyond semaglutide, which peptides pair best with cagrilintide

Lillys triple agonist, retatrutide, delivered powerful weight loss in pivotal phase 3 obesity trial

Immunity 35 , 596610 (2011)